Sean Grant - 19 Aug 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Financial Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
19 Aug 2022
Net transactions value
$0
Form type
4
Filing time
23 Aug 2022, 16:06:15 UTC
Previous filing
18 Feb 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Award $0 +33,750 +2223% $0.000000 35,268 19 Aug 2022 Direct F1
holding VERA Class A Common Stock 2,816 19 Aug 2022 By IRA
holding VERA Class A Common Stock 335 19 Aug 2022 By Roth IRA
holding VERA Class A Common Stock 857 19 Aug 2022 By Spouse's IRA
holding VERA Class A Common Stock 992 19 Aug 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date.